Drug
Incb001158
Incb001158: highest development phase Phase 1, developed by Incyte. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Incyte
Trials
| Drug | Phase | Indication |
|---|---|---|
| INCB001158 NCT02903914 | Phase 1 | Metastatic Cancer |
Latest
No recent events.
Follow Incb001158 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.